Cell and cytokine profile in nasal secretions in cystic fibrosis

Journal of Cystic Fibrosis

Volumn 1, Issue 3, 2002, Pages 110-115

  Bergoin, Cyrille ^a   Gosset, Philippe ^b   Lamblin, Catherine ^b,c   Bolard, Florence ^a   Turck, Dominique ^a   Tonnel, André Bernard ^a,b   Wallaert, Benot ^a,b  

^a LILLE UNIVERSITY HOSPITAL   (France)

^b INSTITUT PASTEUR DE LILLE   (France)

^c Centre Hospitalier de LENS   (France)

Author keywords

Cystic fibrosis; Eosinophil; Inflammation; Interleukin 5; Interleukin 8; Nasal lavage; Nasal polyposis; Neutrophil

Indexed keywords

ANTIBIOTIC AGENT; AUTACOID; BIOLOGICAL MARKER; CYTOKINE; EOSINOPHIL CATIONIC PROTEIN; EOSINOPHIL GRANULE PROTEINS; INTERLEUKIN 5; INTERLEUKIN 8; PLASMA PROTEIN; RIBONUCLEASE; STEROID;

ADOLESCENT; ANTIBIOTIC THERAPY; ARTICLE; CELL COUNT; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CYSTIC FIBROSIS; CYTOLOGY; DISEASE COURSE; EOSINOPHIL; EPITHELIUM CELL; FEMALE; GENE MUTATION; GENOTYPE; HUMAN; IMMUNOLOGY; INFLAMMATORY CELL; LEUKOCYTE; LEUKOCYTE DIFFERENTIAL COUNT; MALE; NEUTROPHIL; NOSE MUCOSA; NOSE MUCUS; NOSE POLYP; NOSE SECRETION; PROSPECTIVE STUDY; SWEAT TEST;

EID: 0036743565     PISSN: 15691993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1569-1993(02)00072-3     Document Type: Article

References (37)

1. Davis PB, Drumm M, Konstan MW. Cystic fibrosis. Am J Respir Crit Care Med 1996;154:1229-56.
2. De Gaudemar I, Contencin P, Van den Abbeele T, Munck A, Navarro J, Narcy P. Is nasal polyposis in cystic fibrosis a direct manifestation of genetic mutation or a complication of chronic infection? Rhinology 1996;34:194-7.
3. Jorissen MB, De Boeck K, Cuppens H. Genotype-phenotype correlations for the paranasal sinuses in cystic fibrosis. Am J Respir Crit Care Med 1999;159:1412-6.
4. Kerrebijn JDF, Poublon RML, Overbeek SE. Nasal and paranasal disease in adult cystic fibrosis patients. Eur J Respir 1992;5:1239-42.
5. Radenne F, Lamblin C, Vandezande LM, et al. Quality of life in nasal polyposis. J Allergy Clin Immunol 1999;104:79-84.
6. Rowe-Jones JM, Mackay IS. Endoscopic sinus surgery in the treatment of cystic fibrosis with nasal polyposis. Laryngoscope 1996;106:1540-4.
7. Stem RC, Boat TF, Wood RE, Matthews LW, Doeshuk CF. Treatment and prognosis of nasal polyps in cystic fibrosis. Am J Dis Child 1982;136:1067-70.
8. Lamblin C, Brichet A, Perez T, Darras J, Tonnel AB, Wallaert B. Long-term follow-up of pulmonary function in patients with nasal polyposis. Am J Respir Crit Care Med 2000;161:406-13.
9. Umetsu DT, Moss RB, King VV, Lewiston NJ. Sinus disease in patients with severe cystic fibrosis: relation to pulmonary exacerbation. Lancet 1990;335:1077-8.
10. Tos M, Mogensen C, Thomsen J. Nasal polyps in cystic fibrosis. J Laryngol Otol 1977;91:827-35.
11. Kramer MF, Rasp G. Nasal polyposis: eosinophils and interleukin-5. Allergy 1999;54:669-80.
12. Sorensen H, Mygind N, Tygstrup I, Winge Flensborg E. Histology of nasal polyps of different etiology. Rhinology 1977;15:121-8.
13. Oppenheimer EH, Rosentein BJ. Differential pathology of nasal polyps in cystic fibrosis and atopy. Lab Invest 1979;40:445-9.
14. Rowe-Jones JM, Shembekar M, Trendell-Smith N, Mackay IS. Polypoidal rhinosinusitis in cystic fibrosis: a clinical and histopathological study. Clin Otolaryngol 1997;22:167-71.
15. Bachert C, Wagenmann M, Rudack C, et al. The role of cytokines in infectious sinusitis and nasal polyposis. Allergy 1998;53:2-13.
16. Leonard EJ, Yoshimura T. Neutrophil attractant/activation proteine-1 (NAP-Interleukin 8). Am J Respir Cell Mol Biol 1990;2:479-86.
17. Sanderson CJ. Interleukin-5, eosinophils, and disease. Blood 1992;79:3101-9.
18. Venge P, Bystrom J, Carlson M, Hakanson L, Karawacjzyk M, Peterson C, Seveus L, Brulson A. Eosinophil cationic protein (ECP): molecular and biological properties and the use of ECP as a marker of eosinophil activation in disease. Clin Exp Allergy 1999;9:1172-86.
19. Naclerio RM, Meier HL, Kagey-Sobotka A, et al. Mediator release after nasal airway challenge with allergen. Am Rev Respir Dis 1983;128:597-602.
20. Noah TL, Black HR, Cheng PW, Wood RE, Leigh M. Nasal and bronchoalveolar lavage fluid cytokines in early cystic fibrosis. J Inf Dis 1997;175:638-47.
21. Wang D, Brihaye P, Smitz J, De Waele M, Clement P. Inflammatory cells and mediator concentrations in nasal secretions of patients with cystic fibrosis. Acta Otolaryngol 1996;11:472-6.
22. Weber A, Kieffer J, Peters S, Schneider M, Bargon J, May A. Eosinophilic cationic protein as a marker of nasal inflammation in patients with cystic fibrosis. Laryngoscope 1999;190:1696-702.
23. Lesprit E, Escudier E, Roger G, et al. Characterization of inflammatory reaction in upper airways of cystic fibrosis patients. Histol Histopathol 2000;15:395-402.
24. Bonfield TL, Panuska JR, Konstan MW, et al. Inflammatory cytokines in cystic fibrosis lungs. Am J Respir Crit Care Med 1995;152:2111-8.
25. Dean TP, Dai Y, Shute JK, Church MK, Warner JO. Interleukin-8 concentrations are elevated in bronchoalveolar lavage, sputum, and sera of children with cystic fibrosis. Pediatr Res 1993;34:159-61.
26. Döring G. The role of elastase in chronic inflammation. Am J Respir Crit Care Med 1994;150:S114-S117.
27. Khan TZ, Wagener JS, Bost T, Martinez J, Accurso FJ, Riches DW. Early pulmonary inflammation in infants with cystic fibrosis. Am J Respir Crit Care Med 1995;151:1075-82.
28. Osika E, Cavaillon JM, Chadelat K, et al. Distinct sputum cytokine profiles in cystic fibrosis and other chronic inflammatory airway diseases. Eur Respir J 1999;14:339-46.
29. Ruef C, Jefferson DM, Schlegel-Haueter SE, Suter S. Regulation of cytokine secretion by cystic fibrosis airway epithelial cells. Eur Respir J 1993;6:1429-36.
30. Schuster A, Haarmann A, Wahn V. Cytokines in neutrophil-dominated airway inflammation in patients with cystic fibrosis. Eur Arch Otorhinolaryngol 1995;252:S59-S60.
31. Wojnarowski C, Fischer T, Hofbauer E, et al. Cytokine expression in bronchial biopsies of cystic fibrosis patients with and without acute exacerbation. Eur Respir J 1999;14:1136-44.
32. Wolter JM, Rodwell RL, Bowler SD, McCormack JG. Cytokines and inflammatory mediators do not indicate acute infection in cystic fibrosis. Clin Diagn Lab Immunol 1999;6:260-5.
33. Henriksson G, Westrin KM, Karpati F, Wilkström AC, Siterna P, Hjelte L. Nasal polyposis in cystic fibrosis. Clinical endoscopic study with nasal lavage fluid analyses. Chest 2002;121:40-7.
34. Noah TL, Henderson FW, Henry MM, Peden DB, Devlin RB. Nasal lavage cytokines in normal, allergic, and asthmatic school-age children. Am J Respir Crit Care Med 1995;152:1290-5.
35. Koller DY, Götz M, Eichler I, Urbanek R. Eosinophilic activation in cystic fibrosis. Thorax 1994;49:496-9.
36. Sur S, Glitz DG, Kita H, et al. Localization of eosinophil-derived neurotoxin and eosinophil cationic protein in neutrophilic leukocytes. J Leukoc Biol 1998;63:715-22.
37. Bolard F, Gosset P, Lamblin C, Bergoin C, Tonnel AB, Wallaert B. Cell and cytokine profiles in nasal secretions from patients with nasal polyposis: effects of topical steroids and surgical treatment. Allergy 2001;56:333-8.